We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GALT icon
7376
PUT
Galectin Therapeutics
GALT
$342M
$69K ﹤0.01%
+20,600
New +$52.1K
GSAT icon
7377
PUT
Globalstar
GSAT
$10.6B
$69K ﹤0.01%
3,527
-2,860
-45% -$65.1K
MUX icon
7378
CALL
McEwen Inc
MUX
$1.16B
$69K ﹤0.01%
3,010
+1,740
+137% +$35.1K
SANW
7379
CALL
DELISTED
S&W Seed Co
SANW
$69K ﹤0.01%
+937
New +$58.9K
RJA
7380
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Agriculture Total Return
RJA
$69K ﹤0.01%
+11,469
New +$69.2K
MDWD icon
7381
MediWound
MDWD
$176M
$68K ﹤0.01%
+2,194
New +$73.9K
SPWH icon
7382
CALL
Sportsman's Warehouse
SPWH
$46.8M
$68K ﹤0.01%
+10,300
New +$49.4K
VUZI icon
7383
CALL
Vuzix
VUZI
$224M
$68K ﹤0.01%
+10,800
New +$62.5K
NYMX
7384
CALL
DELISTED
Nymox Pharmaceutical Corp
NYMX
$68K ﹤0.01%
20,600
-1,000
-5% -$3.65K
SEAC
7385
DELISTED
Seachange International Inc
SEAC
$68K ﹤0.01%
+865
New +$51.1K
TA
7386
DELISTED
TravelCenters of America LLC
TA
$67K ﹤0.01%
+3,276
New +$76K
TCON
7387
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$66K ﹤0.01%
+99
New +$59.8K
PLUR icon
7388
Pluri
PLUR
$18.3M
$65K ﹤0.01%
590
+244
+71% +$30.5K
TTPH
7389
PUT
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$65K ﹤0.01%
+515
New +$65.9K
LABD icon
7390
CALL
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$41.2M
$64K ﹤0.01%
7
-1
-13% -$9.96K
PTN
7391
Palatin Technologies
PTN
$17.7M
$64K ﹤0.01%
60
+13
+28% +$13.5K
KDMN
7392
DELISTED
Kadmon Holdings, Inc.
KDMN
$64K ﹤0.01%
+17,594
New +$62.8K
FATE icon
7393
Fate Therapeutics
FATE
$294M
$63K ﹤0.01%
+10,370
New +$46.3K
KMDA icon
7394
Kamada
KMDA
$433M
$63K ﹤0.01%
+13,184
New +$62.1K
WTI icon
7395
PUT
W&T Offshore
WTI
$554M
$63K ﹤0.01%
19,000
+6,300
+50% +$19.5K
ISEE
7396
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$63K ﹤0.01%
20,100
+4,200
+26% +$11.8K
TNAV
7397
DELISTED
Telenav Inc.
TNAV
$63K ﹤0.01%
+11,535
New +$64.4K
ANTH
7398
CALL
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$63K ﹤0.01%
+38,300
New +$65.9K
LLEX
7399
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
$63K ﹤0.01%
+12,311
New +$59.4K
AENZ
7400
DELISTED
Aenza S.A.A.
AENZ
$62K ﹤0.01%
+7,298
New +$82.7K

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.